{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:02:36Z","timestamp":1791946956180,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jacobus Stichting"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05389-z","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:45:35Z","timestamp":1767012335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Paradigm shift in patients with multiple brain metastases from whole brain radiotherapy to high precision multimodality treatment including stereotactic radiotherapy"],"prefix":"10.1007","volume":"176","author":[{"given":"Jeroen","family":"Crouzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Mast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs","family":"van der Vaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi Nandoe","family":"Tewarie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Nabuurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"Wiggenraad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Kiderlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"van der Voort van Zyp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Petoukhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marike","family":"Broekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Zindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"11","key":"5389_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037\u20131044. https:\/\/doi.org\/10.1016\/S1470-2045(09)70263-3","journal-title":"Lancet Oncol"},{"issue":"2","key":"5389_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol 29(2):134\u2013141. https:\/\/doi.org\/10.1200\/JCO.2010.30.1655","journal-title":"J Clin Oncol"},{"issue":"1","key":"5389_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"R Soffietti","year":"2013","unstructured":"Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG et al (2013) A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: Quality-of-life results. J Clin Oncol 31(1):65\u201372. https:\/\/doi.org\/10.1200\/JCO.2011.41.0639","journal-title":"J Clin Oncol"},{"issue":"4","key":"5389_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV, Farace E, Jane H, Anderson SK et al (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases a randomized clinical trial. JAMA 316(4):401\u2013409. https:\/\/doi.org\/10.1001\/jama.2016.9839","journal-title":"JAMA"},{"key":"5389_CR5","doi-asserted-by":"publisher","unstructured":"Aizer A, Tanguturi SK, Benham G, Brown PD, Cagney D, Catalano PJ et al (2025) Stereotactic radiation versus hippocampal avoidance whole brain radiation in patients with 5\u201320 brain metastases: a multicenter, phase 3 randomized trial ASCO annual meeting. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.2011","DOI":"10.1200\/JCO.2025.43.16_suppl.2011"},{"key":"5389_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2021.03.022","author":"J Kraft","year":"2021","unstructured":"Kraft J, Timmeren JEV, Mayinger M, Frei S, Stark LS, Krayenbuehl J et al (2021) Distance to isocenter is not associated with an increased risk for local failure in LINAC-based Single-Isocenter stereotactic radiosurgery (SRS) or radiotherapy (SRT) for multiple brain metastases. Radiother Oncol. https:\/\/doi.org\/10.1016\/j.radonc.2021.03.022","journal-title":"Radiother Oncol"},{"issue":"1","key":"5389_CR7","doi-asserted-by":"publisher","first-page":"15722","DOI":"10.1038\/s41598-025-01034-x","volume":"15","author":"JA Crouzen","year":"2025","unstructured":"Crouzen JA, Zindler JD, Mast ME, Kleijnen JJE, Versluis MC, Hashimzadah M et al (2025) Local recurrence and radionecrosis after single-isocenter multiple targets stereotactic radiotherapy for brain metastases. Sci Rep 15(1):15722. https:\/\/doi.org\/10.1038\/s41598-025-01034-x","journal-title":"Sci Rep"},{"issue":"8","key":"5389_CR8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa1805453","volume":"379","author":"HA Tawbi","year":"2018","unstructured":"Tawbi HA, Forsyth PA, Algazi A, Hamid O, Hodi FS, Moschos SJ et al (2018) Combined nivolumab and ipilimumab in melanoma metastatic to the brain. N Engl J Med 379(8):722\u2013730. https:\/\/doi.org\/10.1056\/NEJMoa1805453","journal-title":"N Engl J Med"},{"issue":"1","key":"5389_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1158\/1078-0432.CCR-19-1871","volume":"27","author":"N Colclough","year":"2021","unstructured":"Colclough N, Chen K, Johnstrom P, Strittmatter N, Yan Y, Wrigley GL et al (2021) Preclinical comparison of the Blood-brain barrier permeability of osimertinib with other EGFR TKIs. Clin Cancer Res 27(1):189\u2013201. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1871","journal-title":"Clin Cancer Res"},{"issue":"8","key":"5389_CR10","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jtho.2023.04.021","volume":"18","author":"M Reck","year":"2023","unstructured":"Reck M, Ciuleanu TE, Lee JS, Schenker M, Zurawski B, Kim SW et al (2023) Systemic and intracranial outcomes with First-Line nivolumab plus ipilimumab in patients with metastatic NSCLC and baseline brain metastases from checkmate 227 part 1. J Thorac Oncol 18(8):1055\u20131069. https:\/\/doi.org\/10.1016\/j.jtho.2023.04.021","journal-title":"J Thorac Oncol"},{"issue":"11","key":"5389_CR11","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","volume":"32","author":"E Le Rhun","year":"2021","unstructured":"Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F et al (2021) EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol 32(11):1332\u20131347. https:\/\/doi.org\/10.1016\/j.annonc.2021.07.016","journal-title":"Ann Oncol"},{"issue":"2","key":"5389_CR12","doi-asserted-by":"publisher","first-page":"e000024","DOI":"10.1136\/esmoopen-2015-000024","volume":"1","author":"AS Berghoff","year":"2016","unstructured":"Berghoff AS, Schur S, Fureder LM, Gatterbauer B, Dieckmann K, Widhalm G et al (2016) Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers. ESMO Open 1(2):e000024. https:\/\/doi.org\/10.1136\/esmoopen-2015-000024","journal-title":"ESMO Open"},{"issue":"32","key":"5389_CR13","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.20.01255","volume":"38","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU et al (2020) Survival in patients with brain metastases: summary report on the updated Diagnosis-Specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol 38(32):3773\u20133784. https:\/\/doi.org\/10.1200\/JCO.20.01255","journal-title":"J Clin Oncol"},{"issue":"1","key":"5389_CR14","doi-asserted-by":"publisher","first-page":"vdad015","DOI":"10.1093\/noajnl\/vdad015","volume":"5","author":"M Parker","year":"2023","unstructured":"Parker M, Jiang K, Rincon-Torroella J, Materi J, Azad TD, Kamson DO et al (2023) Epidemiological trends, prognostic factors, and survival outcomes of synchronous brain metastases from 2015 to 2019: a population-based study. Neurooncol Adv 5(1):vdad015. https:\/\/doi.org\/10.1093\/noajnl\/vdad015","journal-title":"Neurooncol Adv"},{"issue":"6","key":"5389_CR15","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16(6):e270\u2013e8. https:\/\/doi.org\/10.1016\/S1470-2045(15)70057-4","journal-title":"Lancet Oncol"},{"key":"5389_CR16","doi-asserted-by":"publisher","first-page":"110936","DOI":"10.1016\/j.radonc.2025.110936","volume":"208","author":"L Lauwens","year":"2025","unstructured":"Lauwens L, Ribeiro MF, Zegers CML, Hoyer M, Alapetite C, Blomstrand M et al (2025) Systematic review of MRI alterations in the brain following proton and photon radiation therapy: towards a uniform European particle therapy network (EPTN) definition. Radiother Oncol 208:110936. https:\/\/doi.org\/10.1016\/j.radonc.2025.110936","journal-title":"Radiother Oncol"},{"key":"5389_CR17","first-page":"1","volume":"164","author":"NA Hilkens","year":"2020","unstructured":"Hilkens NA, Enting RH, Hendriks LEL, Lagerwaard FJ, de Vos FYFL, Gijtenbeek JMM (2020) Herziene Richtlijn \u2018Hersenmetastasen\u2019. Ned Tijdschr Geneeskd 164:1\u20134","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"10055","key":"5389_CR18","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/S0140-6736(16)30825-X","volume":"388","author":"P Mulvenna","year":"2016","unstructured":"Mulvenna P, Nankivell M, Barton R, Faivre-Finn C, Wilson P, McColl E et al (2016) Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet 388(10055):2004\u20132014. https:\/\/doi.org\/10.1016\/S0140-6736(16)30825-X","journal-title":"Lancet"},{"key":"5389_CR19","doi-asserted-by":"publisher","unstructured":"Raza GH, Capone L, Tini P, Giraffa M, Gentile P, Minniti G (2022) Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systems. Radiat Oncol 17(1). https:\/\/doi.org\/10.1186\/s13014-022-02086-3","DOI":"10.1186\/s13014-022-02086-3"},{"issue":"1","key":"5389_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.adro.2019.08.013","volume":"5","author":"JD Palmer","year":"2020","unstructured":"Palmer JD, Sebastian NT, Chu J, DiCostanzo D, Bell EH, Grecula J et al (2020) Single-Isocenter multitarget stereotactic radiosurgery is safe and effective in the treatment of multiple brain metastases. Adv Radiation Oncol 5(1):70\u201376. https:\/\/doi.org\/10.1016\/j.adro.2019.08.013","journal-title":"Adv Radiation Oncol"},{"issue":"1100","key":"5389_CR21","doi-asserted-by":"publisher","first-page":"20190004","DOI":"10.1259\/bjr.20190004","volume":"92","author":"Y Ueda","year":"2019","unstructured":"Ueda Y, Ohira S, Yamazaki H, Mabuchi N, Higashinaka N, Miyazaki M et al (2019) Dosimetric performance of two linear accelerator-based radiosurgery systems to treat single and multiplebrain metastases. Br J Radiol 92(1100):20190004. https:\/\/doi.org\/10.1259\/bjr.20190004","journal-title":"Br J Radiol"},{"key":"5389_CR22","doi-asserted-by":"publisher","first-page":"1221097","DOI":"10.3389\/fimmu.2023.1221097","volume":"14","author":"A Rios-Hoyo","year":"2023","unstructured":"Rios-Hoyo A, Arriola E (2023) Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic. Front Immunol 14:1221097. https:\/\/doi.org\/10.3389\/fimmu.2023.1221097","journal-title":"Front Immunol"},{"key":"5389_CR23","doi-asserted-by":"publisher","unstructured":"Sadagopan N, Komlodi-Pasztor E, Veytsman I (2025) Immunotherapy benefits for large brain metastases in non-small cell lung cancer. Oncologist 30(8). https:\/\/doi.org\/10.1093\/oncolo\/oyae314","DOI":"10.1093\/oncolo\/oyae314"},{"key":"5389_CR24","doi-asserted-by":"publisher","first-page":"e479","DOI":"10.1016\/j.wneu.2020.10.124","volume":"146","author":"M Yamamoto","year":"2021","unstructured":"Yamamoto M, Serizawa T, Sato Y, Higuchi Y, Kasuya H (2021) Stereotactic radiosurgery results for patients with 5\u201310 versus 11\u201320 brain metastases: A retrospective cohort study combining 2 databases totaling 2319 patients. World Neurosurg 146:e479\u2013e91. https:\/\/doi.org\/10.1016\/j.wneu.2020.10.124","journal-title":"World Neurosurg"},{"key":"5389_CR25","doi-asserted-by":"publisher","unstructured":"Kinj R, Hottinger AF, Bohlen TT, Ozsahin M, Vallet V, Dunet V et al (2024) Long-Term results of stereotactic radiotherapy in patients with at least 10 brain metastases at diagnosis. Cancers (Basel) 16(9). https:\/\/doi.org\/10.3390\/cancers16091742","DOI":"10.3390\/cancers16091742"},{"key":"5389_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae201","author":"RA El Shafie","year":"2024","unstructured":"El Shafie RA, Bernhardt D, Welzel T, Schiele A, Schmitt D, Thalmann P et al (2024) Stereotactic radiosurgery for 1\u201310 brain metastases to avoid Whole-Brain Radiotherapy - Results of the CYBER-SPACE randomized phase 2 trial. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noae201","journal-title":"Neuro Oncol"},{"issue":"5","key":"5389_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/0284186X.2017.1418534","volume":"57","author":"PM Jeene","year":"2018","unstructured":"Jeene PM, de Vries KC, van Nes JGH, Kwakman JJM, Wester G, Rozema T et al (2018) Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014. Acta Oncol 57(5):637\u2013643. https:\/\/doi.org\/10.1080\/0284186X.2017.1418534","journal-title":"Acta Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05389-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05389-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05389-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:47:00Z","timestamp":1769773620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05389-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5389"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05389-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}